皮下的避孕植入市场份额,Size, Trends, Industry Analysis Report, By Product (Levonorgestrel Implant, Etonogestrel Implant, Others); By End-Use (Hospitals, Clinics, Diagnostic Centers, Others); By Regions; Segment Forecast, 2021 - 2028

报告摘要

全球潜水避孕植入物市场规模在2020年的757.2百万美元的价值下降，预计预测期间的CAGR在3.4％的增长率下。避孕植入物是激素的避孕药，其插入上臂。植入物负责释放体内的激素以预防妊娠。

了解有关此报告的更多信息：request for sample pages

The subdermal contraceptive implants are easy to use and offer high effectiveness. Subdermal contraceptive implants provide birth control for around three years, following which fertility is returned upon removal of the implant. The increasing number of abortions, growing demand for long-term birth control methods, and growing investments in the healthcare sector are some factors expected to fuel the demand for subdermal contraceptive implants during the forecast period.

技术进步与研究与发展支持市场增长的重大投资。市场领先的玩家在市场上推出和收购增加了对全球对底施避孕植入物的需求。2018年2月，DKT国际合作与上海大华药业有限公司营销左血管株，这是一种避孕植入物。

The collaboration is aimed at improving the accessibility, availability, and affordability of Levoplant. Shanghai Dahua Pharmaceutical Co., Ltd. aims at strengthening its manufacturing of Levoplant through the partnership, whereas DKT plans to launch Levoplant into new markets, along with marketing, and servicing customers.

行业动态

Growth Drivers
The market demand for subdermal contraceptive implants has increased owing to their high effectiveness, and affordability. Increasing preference for these implants among women has resulted from their increased safety, and efficacy for three years without intervention. These implants can be easily removed for a quick return to fertility. The contraceptive operates through modification of the endometrium, suppression of ovulation, and increased viscosity of the cervical mucus.

The global market for subdermal contraceptive implants is fueled by increasing demand from countries such as China, Japan, and India, a growing population, and rising healthcare expenditure. Rising health concerns, improving healthcare infrastructure, and growing awareness regarding preventive healthcare have further increased the demand for these implants.

潜水避孕植入物的全球市场受到提高对避孕药的意识，对性健康的担忧，以及各国政府对人口控制的举措的担忧。越来越多的可支配收入，改变的生活方式和市场参与者推出经济实惠的避孕药，将支持市场的增长。

A growing number of unwanted pregnancies and abortions and technological advancements boost the adoption of subdermal contraceptive implants. Global players are expanding into developing countries to tap potential, further boosting the market growth for subdermal contraceptive implants.

潜水避孕植入市场报告范围

该市场主要根据产品，最终使用和地区进行分段。

由产品	通过最终使用	按地区
Levonorgestrel植入物 Etonogestrel Implant Others	医院 Clinics 诊断中心 Others	北美（美国，加拿大） Europe (Germany, UK, France, Italy, Spain, RoE) 亚太地区（中国，印度，日本，韩国，罗阿普克） 拉丁美洲（巴西，墨西哥，哥伦比亚，罗拉姆） 中东和非洲（沙特阿拉伯，南非，以色列，阿联酋，罗姆省）

了解有关此报告的更多信息：request for sample pages

产品展望

基于产品，将脱汞避孕植入物的市场分段为左旋组织植入物，Etonogestrel植入物等。Etonogestrel Subdermal避孕植入物段在2020年占据了全球底皮避孕植入物市场。

Etonogestrel植入物小，柔韧，并且放置在上臂的皮肤下。它是一个长效的避孕选择解决方案，提供持续避孕期长达3年。人口越来越多，改变的生活方式和与避孕相关的不断增长的意识增加了对Etonogestrel植入物的需求。

最终使用前景

The end-use subdermal contraceptive implants industry segment has been divided into hospitals, clinics, diagnostic centers, and others. The hospital segment dominated the global subdermal contraceptive implants market in 2019. The high traffic environment, advanced healthcare infrastructure, availability of advanced medical equipment and services, and presence of experienced medical professionals in hospitals support the growth of this segment.

地理概述

北美在2020年占据了番石切避孕植入物的全球市场。成立的医疗保健基础设施，日益增长的研发活动以及技术进步是归因于该地区的增长的一些因素。乐动娱乐官网在该地区注册的堕胎越来越多，推动市场增长。

Rising health concerns, a growing number of unwanted pregnancies, increasing awareness regarding efficient contraceptive and introduction of affordable implants has increased the demand in the region. High disposable income, increasing government initiatives, and the introduction of supportive healthcare programs further supplement the market growth for subdermal contraceptives.

Competitive Landscape

Subdermal避孕药业的领先市场参与者包括Karex Industries，拜耳AG，Teva Pharmaceutical Industries Ltd.，凯乐动体育网址多少尔梅蒂姆GmbH，Allergan Plc，上海大华药业有限公司，女性卫生公司，Reckitt Benckiser Group Plc，Merck＆公司，Inc。和Mayer Laboratories。这些玩家正在扩大他们在各种地理位置的业务，并在发展中国区进入新市场，以扩大客户群，加强市场存在。